Insights

23.02.22

By Dr. Diane Seimetz

Why scientific due diligence is key to a successful M&A

11.02.22

By Jörg Schneider

The field of extracellular vesicles is a nascent and rapidly..

24.01.22

Small pharmaceutical company with EMA approved gene therapy in need for support with HTA assessment

24.01.22

Small pharmaceutical company with EMA approved gene therapy in need for support with HTA assessment

24.01.22

European client initiating US development of its gene therapy product.

24.01.22

Client was a small biotech company developing an autologous cell product for cartilage defects in

Previous 1 3 4 Next